Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

Marrero et al. (Fri,) studied this question.

www.synapsesocial.com/papers/69d96a3b8988aeabbe68546e — DOI: https://doi.org/10.1002/hep.29913

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Immune Checkpoint Blockade in Cancer Therapy· 2015 · 2,728 citations
2. Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives· 2003 · 273 citations
3. Testosterone regulation of cyclin E kinase: A key factor in determining gender differences in hepatocarcinogenesis· 2015 · 31 citations
4. Hepatocellular carcinoma· 2018 · 5,566 citations
5. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial· 2018 · 5,390 citations